← All Companies
ProMIS Neurosciences Inc.
PMN · Nasdaq · SIC 2834: Pharmaceutical Preparations
Business Summary PARTI Overview ProMIS has in-licensed a patented technology platform with the potential to deliver a portfolio of antibody therapies, therapeutic vaccines, and other therapies derived from antibodies for neurodegenerative diseases and other misfolded protein diseases, which may include Alzheimers disease, multiple system atrophy, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, Parkinsons disease, progressive supranuclear palsy, corticobasal degeneration (respectively, AD, MSA, ...
Next Earnings Q2 FY2026 — expected 2026-09-17
Key Facts from Earnings Calls Type Subject Detail Quarter topic_mention PMN discussed_in_filing Artificial Intelligence topic_mention PMN discussed_in_filing Cybersecurity topic_mention PMN discussed_in_filing Trusted Computing topic_mention PMN discussed_in_filing Blockchain & Crypto topic_mention PMN discussed_in_filing Supply Chain topic_mention PMN discussed_in_filing Regulation topic_mention PMN discussed_in_filing Healthcare & Bio topic_mention PMN discussed_in_filing Platform & Ecosystem topic_mention PMN discussed_in_filing Sovereign & Government topic_mention PMN discussed_in_filing Artificial Intelligence topic_mention PMN discussed_in_filing Cybersecurity topic_mention PMN discussed_in_filing Trusted Computing topic_mention PMN discussed_in_filing Blockchain & Crypto topic_mention PMN discussed_in_filing Supply Chain topic_mention PMN discussed_in_filing Regulation topic_mention PMN discussed_in_filing Healthcare & Bio topic_mention PMN discussed_in_filing Platform & Ecosystem topic_mention PMN discussed_in_filing Sovereign & Government topic_mention PMN discussed_in_filing Artificial Intelligence topic_mention PMN discussed_in_filing Cybersecurity
Annual Reports (10-K) Filed Period Accession Source Full Text 2026-03-25 2025-12-31 0001104659-26-034554 EDGAR 95K words 2025-03-31 2024-12-31 0001558370-25-004068 EDGAR — 2024-04-01 2023-12-31 0001558370-24-004532 EDGAR — 2023-03-08 2022-12-31 0001558370-23-003167 EDGAR —
Quarterly Reports (10-Q) Filed Period Accession Source Full Text 2025-11-12 2025-09-30 0001104659-25-109719 EDGAR 25K words 2025-08-13 2025-06-30 0001558370-25-011299 EDGAR — 2025-05-12 2025-03-31 0001558370-25-007255 EDGAR — 2024-11-14 2024-09-30 0001558370-24-015634 EDGAR — 2024-08-08 2024-06-30 0001558370-24-011476 EDGAR — 2024-05-14 2024-03-31 0001558370-24-008145 EDGAR — 2023-11-14 2023-09-30 0001558370-23-019048 EDGAR — 2023-08-14 2023-06-30 0001558370-23-014914 EDGAR — 2023-05-15 2023-03-31 0001558370-23-009954 EDGAR — 2022-11-14 2022-09-30 0001104659-22-117657 EDGAR — 2022-08-12 2022-06-30 0001104659-22-089668 EDGAR —
Recent Current Reports (8-K) Filed Accession Source Full Text 2026-03-25 0001104659-26-034162 EDGAR 3K words 2026-01-30 0001104659-26-008325 EDGAR — 2025-12-16 0001104659-25-121627 EDGAR — 2025-11-24 0001104659-25-115182 EDGAR — 2025-11-19 0001104659-25-113978 EDGAR — 2025-11-12 0001104659-25-109714 EDGAR — 2025-10-24 0001104659-25-102137 EDGAR — 2025-09-30 0001104659-25-095032 EDGAR — 2025-09-03 0001558370-25-011845 EDGAR — 2025-08-19 0001558370-25-011671 EDGAR —
94 total filings indexed. 69 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers Company Identity
CIK 0001374339
Ticker PMN
Exchange Nasdaq
SIC 2834: Pharmaceutical Preparations
Incorporated Z4
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 3c518f3ec6f0c1d04c2dd582a2a945ae8019cf20768e329a96a6bc9a2f80c08f
parent: 22941297644f440d079753ed6755af0d5c8a9be14756925db5a0e6f11676f849
content hash: a3fe5489c8ba86b892c96955febcb2ce25d4a17c8e4383c7c2ee1e38b0b62a68
signed: 2026-04-13T04:46:56.876Z
sources: 15 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf